We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
A tiny diabetes drug maker in Norway decided to get into energy trading — and failed spectacularly
Finance Finance Headlines News
Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.